Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer
about
Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies.Biosynthesis of Violacein, Structure and Function of l-Tryptophan Oxidase VioA from Chromobacterium violaceum.Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors.Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer.IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML
P2860
Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Antitumor activity of the nove ...... triple negative breast cancer
@ast
Antitumor activity of the nove ...... triple negative breast cancer
@en
type
label
Antitumor activity of the nove ...... triple negative breast cancer
@ast
Antitumor activity of the nove ...... triple negative breast cancer
@en
prefLabel
Antitumor activity of the nove ...... triple negative breast cancer
@ast
Antitumor activity of the nove ...... triple negative breast cancer
@en
P2093
P2860
P50
P356
P1433
P1476
Antitumor activity of the nove ...... triple negative breast cancer
@en
P2093
Atanasio Pandiella
Francisco Morís
Jorge Carlos Morales
Luz Elena Núñez
Maria José Gascón-Escribano
María Dolores Cuenca-López
Mónica Gomez-Juarez
Veronique Voisin
P2860
P304
27923-27937
P356
10.18632/ONCOTARGET.4736
P407
P577
2015-09-01T00:00:00Z